rinvoq
abbvie deutschland gmbh & co. kg - upadacitinib - artritis, reumatoidni - imunosupresivi - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
ultiva 2 mg/1 bočica prašak za koncentrat za rastvor za injekciju/infuziju
clinres farmacija d.o.o. - ремифентанил - prašak za koncentrat za rastvor za injekciju/infuziju - 2 mg/1 bočica - 1 bočica sa praškom za koncentrat za rastvor za injekciju/infuziju sadrži: 2 mg remifentanil (u obliku remifentanilhidrohlorida)
ultiva 5 mg/1 bočica prašak za koncentrat za rastvor za injekciju/infuziju
clinres farmacija d.o.o. - ремифентанил - prašak za koncentrat za rastvor za injekciju/infuziju - 5 mg/1 bočica - 1 bočica sa praškom za koncentrat za rastvor za injekciju/infuziju sadrži: 5 mg remifentanil (u obliku remifentanilhidrohlorida)
ultiva 1 mg/1 bočica prašak za koncentrat za rastvor za injekciju/infuziju
clinres farmacija d.o.o. - ремифентанил - prašak za koncentrat za rastvor za injekciju/infuziju - 1 mg/1 bočica - 1 bočica sa praškom za koncentrat za rastvor za injekciju/infuziju sadrži: 1 mg remifentanil (u obliku remifentanilhidrohlorida)
atrasyl 25 mg/2.5 ml rastvor za injekciju/ infuziju
licentis doo sarajevo - atrakurijum бесилат - rastvor za injekciju/ infuziju - 25 mg/2.5 ml - 2,5 ml rastvora za injekciju/infuziju sadrži: 25 mg atrakurijum besilata
atrasyl 50 mg/5 ml rastvor za injekciju/ infuziju
licentis doo sarajevo - atrakurijum бесилат - rastvor za injekciju/ infuziju - 50 mg/5 ml - 5 ml rastvora za injekciju/infuziju sadrži: 50 mg atrakurijum besilata
anbol cardio 100mg gastrorezistentna tableta
"glk pharma" druŠtvo sa ograniČenom odgovornoŠĆu, podgorica - acetilsalicilna kiselina - gastrorezistentna tableta - 100mg
cardiopirin 100mg gastrorezistentna tableta
pharmaswiss - montenegro, pharmaswiss doo beograd, dio stranog druŠtva u podgorici - acetilsalicilna kiselina - gastrorezistentna tableta - 100mg
controloc control
takeda gmbh - pantoprazol - gastroezofagealni refluks - inhibitori protonske pumpe - kratkoročno liječenje simptoma refluksa (npr. žgaravica, regurgitacija kiseline) u odraslih osoba.